BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25386858)

  • 1. Benefit of negative pressure drain within surgical wound after cytoreductive surgery for ovarian cancer.
    Kim SI; Lim MC; Bae HS; Shin SR; Seo SS; Kang S; Park SY
    Int J Gynecol Cancer; 2015 Jan; 25(1):145-51. PubMed ID: 25386858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a subcutaneous negative pressure drain without subcutaneous suture: impact on wound healing in gynecologic surgery.
    Kim SI; Lim MC; Song YJ; Seo SS; Kang S; Park SY
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():94-100. PubMed ID: 24388401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of subcutaneous negative pressure drains on surgical wound healing in ovarian cancer.
    Chung YS; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
    Int J Gynecol Cancer; 2021 Feb; 31(2):245-250. PubMed ID: 32675054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
    Dottino JA; He W; Sun CC; Zhao H; Fu S; Rauh-Hain JA; Suidan RS; Lu KH; Giordano SH; Meyer LA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1195-1202. PubMed ID: 32616627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.
    Lippitt MH; Fairbairn MG; Matsuno R; Stone RL; Tanner EJ; Wick EC; Angarita AC; Roche KL; Levinson KL; Bergstrom JE; Sinno AK; Curless MS; Wethington S; Temkin SM; Efron J; Hobson D; Fader AN
    Obstet Gynecol; 2017 Oct; 130(4):756-764. PubMed ID: 28885412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Postoperative Pain Control for Cytoreductive Surgery in Women With Ovarian Cancer Using Patient-Controlled Epidural Analgesia.
    Oh TK; Lim MC; Lee Y; Yun JY; Yeon S; Park SY
    Int J Gynecol Cancer; 2016 Mar; 26(3):588-93. PubMed ID: 26825838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
    Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
    J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is complete cytoreductive surgery feasible in this patient with ovarian cancer?
    Dessapt AL; Huchon C; Ngo C; Bats AS; Bensaid C; Lecuru F
    Surg Oncol; 2016 Sep; 25(3):326-31. PubMed ID: 27566040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
    Bernard L; Boucher J; Helpman L
    Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
    Narasimhulu DM; Bews KA; Hanson KT; Chang YH; Dowdy SC; Cliby WA
    Gynecol Oncol; 2020 Feb; 156(2):278-283. PubMed ID: 31785863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
    Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
    Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of negative pressure wound therapy on surgical incisions (prevena™) after surgery of pectus deformities reduces wound complications].
    Simon K; Schulz-Drost M; Besendörfer M; Carbon RT; Schulz-Drost S
    Zentralbl Chir; 2015 Apr; 140(2):156-62. PubMed ID: 24647815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328].
    Chintamani ; Singhal V; Singh J; Bansal A; Saxena S
    BMC Cancer; 2005 Jan; 5():11. PubMed ID: 15676064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score.
    da Costa AA; Valadares CV; Mantoan H; Saito A; Salvadori MM; Guimarães AP; Sanches SM; Achatz MI; Baiocchi G
    Int J Gynecol Cancer; 2016 Mar; 26(3):449-55. PubMed ID: 26825830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Infectious Complications in Implant Based Breast Reconstruction: Impact of Early Expansion and Prolonged Drain Use.
    Hanna KR; Tilt A; Holland M; Colen D; Bowen B; Stovall M; Lee A; Wang J; Drake D; Lin K; Uroskie T; Campbell CA
    Ann Plast Surg; 2016 Jun; 76 Suppl 4():S312-5. PubMed ID: 26914348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged Jackson-Pratt drainage in the management of lumbar cerebrospinal fluid leaks.
    Hughes SA; Ozgur BM; German M; Taylor WR
    Surg Neurol; 2006 Apr; 65(4):410-4, discussion 414-5. PubMed ID: 16531215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing Surgical Site Infection with Negative-Pressure Wound Therapy After Open Abdominal Surgery: A Prospective Randomized Controlled Study.
    Li PY; Yang D; Liu D; Sun SJ; Zhang LY
    Scand J Surg; 2017 Sep; 106(3):189-195. PubMed ID: 27609528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of pre-existent bacterial colonization in patients with advanced/relapsed ovarian neoplasms undergoing cytoreductive surgery: a multicenter observational study (BONSAI).
    Fotopoulou C; Rinne N; Ghirardi V; Cunnea P; Drosou A; Tzovaras D; Giudice MT; Scambia G; Fagotti A
    Int J Gynecol Cancer; 2020 Oct; 30(10):1562-1568. PubMed ID: 32817201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
    Gerestein CG; Nieuwenhuyzen-de Boer GM; Eijkemans MJ; Kooi GS; Burger CW
    Eur J Cancer; 2010 Jan; 46(1):102-9. PubMed ID: 19900801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a subcutaneous closed drainage system and antibiotics in obese gynecologic patients.
    Gallup DC; Gallup DG; Nolan TE; Smith RP; Messing MF; Kline KL
    Am J Obstet Gynecol; 1996 Aug; 175(2):358-61; discussion 362. PubMed ID: 8765253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.